Key facts
| Price (PPV) | 107.50 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | fluticasone |
| Class | Nasal preparations |
| ATC code | R01AD12 |
| Manufacturer | GLAXO SMITHKLINE |
| Presentation | Flacon de 120 pulvirésations |
| Hospital price | 67.20 MAD |
| Data collected on | 9/8/2026 |
Indications
Avamys est indiqué chez les adultes, les adolescents et les enfants (à partir de 6 ans). Avamys est indiqué dans le traitement des symptômes de la rhinite allergique Source : https://ec.europa.eu - 22 octobre 2025
Find an open pharmacy
On-call pharmacies near you
About AVAMYS 27.5 µg / pulvérisation
AVAMYS 27.5 µg / pulvérisation belongs to the nasal preparations therapeutic class. In Morocco, this drug is marketed by GLAXO SMITHKLINE and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of AVAMYS 27.5 µg / pulvérisation, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about AVAMYS 27.5 µg / pulvérisation
Answers to common questions from Moroccan patients about this drug.